Unveiling the resistance risk and mechanism of mefentrifluconazole in Colletotrichum scovillei.
IF 3.8
1区 农林科学
Q1 AGRONOMY
Niuniu Shi,Qinghai Wang,Jingyi He,Xuefang Zheng,Yixin Du,Fangluan Gao
求助PDF
{"title":"Unveiling the resistance risk and mechanism of mefentrifluconazole in Colletotrichum scovillei.","authors":"Niuniu Shi,Qinghai Wang,Jingyi He,Xuefang Zheng,Yixin Du,Fangluan Gao","doi":"10.1002/ps.70246","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nColletotrichum scovillei is a major fungal pathogen responsible for anthracnose disease, posing a growing threat to global chili production. Mefentrifluconazole, a novel isopropanol-triazole fungicide, exhibits strong efficacy against a broad spectrum of plant pathogens. However, the resistance risk of mefentrifluconazole in Colletotrichum scovillei and the associated molecular mechanisms remain poorly characterized.\r\n\r\nRESULTS\r\nIn this study, we evaluated the sensitivity of 102 Colletotrichum scovillei isolates to mefentrifluconazole, revealing a half-maximal effective concentration (EC50) value of 0.6924 ± 0.1482 μg mL-1. Through fungicide adaptation, seven stable resistant mutants were generated from four sensitive parental isolates, with resistance factors ranging from 3.73 to 26.51. Compared to their parental isolates, the resistant mutants displayed similar or reduced fitness in terms of growth, sporulation and pathogenicity. Cross-resistance assays indicated that mefentrifluconazole exhibited positive cross-resistance with difenoconazole, propiconazole and prochloraz, but not with pyraclostrobin, florylpicoxamid or fluazinam. Further biochemical analysis demonstrated that mefentrifluconazole treatment resulted in a significantly higher inhibition rate of ergosterol biosynthesis in parental isolates relative to resistant mutants. A similar finding was observed in cell membrane damage assessment. Molecular investigations revealed no mutations in CYP51 paralogs among resistant mutants; however, quantitative analysis confirmed the overexpression of CYP51 paralogs in these isolates following mefentrifluconazole exposure.\r\n\r\nCONCLUSION\r\nTogether, there is a low risk of Colletotrichum scovillei developing resistance to mefentrifluconazole, and the induced overexpression of CYP51 paralogs may contribute to potential mefentrifluconazole resistance in this pathogen. These findings offer significant implications for formulating effective management strategies against anthracnose. © 2025 Society of Chemical Industry.","PeriodicalId":218,"journal":{"name":"Pest Management Science","volume":"127 1","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pest Management Science","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1002/ps.70246","RegionNum":1,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"AGRONOMY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
BACKGROUND
Colletotrichum scovillei is a major fungal pathogen responsible for anthracnose disease, posing a growing threat to global chili production. Mefentrifluconazole, a novel isopropanol-triazole fungicide, exhibits strong efficacy against a broad spectrum of plant pathogens. However, the resistance risk of mefentrifluconazole in Colletotrichum scovillei and the associated molecular mechanisms remain poorly characterized.
RESULTS
In this study, we evaluated the sensitivity of 102 Colletotrichum scovillei isolates to mefentrifluconazole, revealing a half-maximal effective concentration (EC50) value of 0.6924 ± 0.1482 μg mL-1. Through fungicide adaptation, seven stable resistant mutants were generated from four sensitive parental isolates, with resistance factors ranging from 3.73 to 26.51. Compared to their parental isolates, the resistant mutants displayed similar or reduced fitness in terms of growth, sporulation and pathogenicity. Cross-resistance assays indicated that mefentrifluconazole exhibited positive cross-resistance with difenoconazole, propiconazole and prochloraz, but not with pyraclostrobin, florylpicoxamid or fluazinam. Further biochemical analysis demonstrated that mefentrifluconazole treatment resulted in a significantly higher inhibition rate of ergosterol biosynthesis in parental isolates relative to resistant mutants. A similar finding was observed in cell membrane damage assessment. Molecular investigations revealed no mutations in CYP51 paralogs among resistant mutants; however, quantitative analysis confirmed the overexpression of CYP51 paralogs in these isolates following mefentrifluconazole exposure.
CONCLUSION
Together, there is a low risk of Colletotrichum scovillei developing resistance to mefentrifluconazole, and the induced overexpression of CYP51 paralogs may contribute to potential mefentrifluconazole resistance in this pathogen. These findings offer significant implications for formulating effective management strategies against anthracnose. © 2025 Society of Chemical Industry.
揭示玫芬三氟康唑对炭疽病菌的耐药风险及耐药机制。
背景炭疽菌是炭疽病的主要真菌病原体,对全球辣椒生产构成越来越大的威胁。甲苯三氟康唑是一种新型异丙醇-三唑类杀菌剂,对多种植物病原体具有很强的杀灭作用。然而,对美苯三氟康唑在炭疽菌中的耐药风险及其相关分子机制的研究尚不清楚。结果对102株炭疽菌对甲苯三氟康唑的敏感性进行了评价,其半最大有效浓度(EC50)为0.6924±0.1482 μg mL-1。4个敏感亲本菌株经杀菌剂适应化,获得7个稳定的抗性突变体,抗性因子范围为3.73 ~ 26.51。与亲本分离株相比,抗性突变体在生长、产孢和致病性方面表现出相似或降低的适应性。交叉耐药试验表明,甲苯三氟康唑与异丙苯康唑、丙环康唑和丙氯嗪呈阳性交叉耐药,而与吡氯虫酯、氟吡肟和氟嗪南无阳性交叉耐药。进一步的生化分析表明,与耐药突变体相比,甲苯三氟康唑对亲本分离株麦角甾醇生物合成的抑制率明显更高。在细胞膜损伤评估中也观察到类似的发现。分子研究显示耐药突变体中CYP51相似物无突变;然而,定量分析证实,在暴露于甲苯三氟康唑后,这些分离株中CYP51类似物过表达。结论鸡毛炭疽病对甲苯三氟康唑的耐药风险较低,诱导CYP51类似物的过表达可能是该病原菌对甲苯三氟康唑潜在耐药的原因之一。这些发现对制定有效的炭疽病管理策略具有重要意义。©2025化学工业协会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。